003 Effective Strategies for Early Stage Drug Development - Judy Magruder

003 Effective Strategies for Early Stage Drug Development - Judy Magruder

What We Covered
  • 02:10 – Judy Magruder joins the show to discuss her background in early stage drug development and best practices for creating integrated product plans
  • 06:21 – Judy provides her insights on CMC and the importance of identifying effective ways of executing strategy shifts in this ever-changing industry
  • 13:09 – Other communication tools early stage companies can use to meet milestones
  • 14:39 – How to manage expectations and risks as a CMO or head of an early stage drug development company
  • 21:52 – Judy expounds on CMC regulatory challenges that early stage companies face and the importance of developing a plan
  • 26:58 – Ed, Brian and Meranda thank Judy for joining the show
Tweetable Quotes

“Think big picture first and then all the minutia and the smaller, what I call micro-plans, come later. And, I think that when companies take the time to do that upfront and build a registration strategy, ya know, ‘What does the product need to look like when it hits the market,’ all the plans underneath that become that much more valuable and realistic.”

“So, things change all the time. And so, whether you do a weekly meeting or a daily meeting or a sub-team, I just love that people know number one, what the change is because communication is the key. It’s so multi-disciplinary. All these different disciplines depend on each other, so communicating change in a succinct way is very important.”

“There’s so many different ways to communicate what’s important, what’s the critical path, what are the milestones and what’s important to focus on today.”

“It’s like anything in life. Unless you have a plan, there’s no guarantee you’re gonna get there. If you want to increase the probability that you’re going to succeed, you need a plan that shows how you’re gonna get there.”

Relevant Links

International Council fo Harmonisation

Leadership

Design Space InPharmatics - LinkedIn

Design Space InPharmatics - Twitter

Edward Narke on LinkedIn

Judy Magruder on LinkedIn

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(27)

025 - The Parenteral Drug Association & Evolution of Drug Development with Michael Carroll

025 - The Parenteral Drug Association & Evolution of Drug Development with Michael Carroll

What We Covered00:55 – Ed, Meranda and Brian welcome today’s guest, Mike Carroll, who speaks to his background in microbiology and product development  04:28 – Mike talks about his involvement in the ...

12 Maalis 202131min

024 - Quality Management Systems Explained!

024 - Quality Management Systems Explained!

What We Covered00:54 – Ed, Meranda and Brian welcome a special panel of guests to break down today’s topic: Quality Management Systems (QMS) Explained!  07:53 – The panel expounds on the timing necess...

5 Maalis 202138min

023 - A Broadway Performance Analogy for API Process Validations with Jim Mencel

023 - A Broadway Performance Analogy for API Process Validations with Jim Mencel

What We Covered00:52 – Ed, Meranda and Brian welcome back Jim Mencel who shares his extensive experience with process validation07:46 – The importance of Proven Acceptable Range (PAR) and Critical Pro...

26 Helmi 202143min

022 - Filter Validation & How It Impacts Getting Your Product to Market with Shelli Connelly

022 - Filter Validation & How It Impacts Getting Your Product to Market with Shelli Connelly

What We Covered00:51 – Ed, Meranda and Brian introduce today’s guest, Shelli Connelly, who discusses her background and speaks to some of the elements of filter validation  05:41 – Shelli talks about ...

19 Helmi 202132min

021 - Regulatory Odd Couple with Ed Narke & Meranda Parascandola

021 - Regulatory Odd Couple with Ed Narke & Meranda Parascandola

What We Covered00:51 – Meranda and Ed discuss the Regulatory Odd Couple blog series and constructing the CTD Module 3  11:54 – Ed explains the importance of building the Quality Overall Summary (QOS) ...

12 Helmi 20211h

020 - Lessons Gleaned from Twenty Five Years of a Regulatory CMC Life with Ed Narke

020 - Lessons Gleaned from Twenty Five Years of a Regulatory CMC Life with Ed Narke

What We Covered00:54 – Meranda and Brian flip the script by introducing fellow host, Ed Narke as today’s guest01:56 – Ed speaks to his extensive background in CMC and the importance he places on build...

29 Tammi 202148min

019 - Complexity of Project Management in Drug Development with Paul Long

019 - Complexity of Project Management in Drug Development with Paul Long

What We Covered00:55 – Ed, Brian and Meranda welcome to the show Paul Long who shares his well-rounded background as a project management consultant and speaks to some of the benefits and challenges o...

22 Tammi 202143min

018 - 2020: A Year in Review with Ed Narke, Brian Lihou & Meranda Parascandola

018 - 2020: A Year in Review with Ed Narke, Brian Lihou & Meranda Parascandola

What We Covered00:43 – Ed, Brian and Meranda introduce today’s 2020 Year-In-Review show and look back on learnings from Jim Mencel, Dave Adams and Daniel Torok10:11 – Ed, Brian and Meranda reflect bac...

8 Tammi 202152min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-narsisti
rss-valo-minussa-2
rss-hereilla
kesken
ihminen-tavattavissa-tommy-hellsten-instituutti
salainen-paivakirja
rss-liian-kuuma-peruna
rss-duodecim-lehti
rss-koira-haudattuna
rss-suomen-aa-podcast
rss-niinku-asia-on
adhd-podi
rss-monarch-talk-with-alexandra-alexis
rss-arkea-ja-aurinkoa-podcast-espanjasta
ilona-rauhala
rss-rahamania
dear-ladies